While not yet approved, its development represents a major step forward in oral weight management treatments
And I think the big question is to determine whether improvements in disease activity that we might see, whether they're entirely due to weight loss, or are there actually direct anti-inflammatory effects of these medications, which could be really interesting
Product information is provided for scientific and handling context only
This article is for general educational purposes and is not a substitute for an in-person medical evaluation, diagnosis, or treatment
As of March 2026, two trials are actively recruiting new participants: the Maintenance trial (NCT06859268, testing dose reduction after initial weight loss) and a new enrollment trial (NCT07232719, 250 participants with obesity or overweight)